Mithra Completes Pediatric Study of ESTELLE® in Adolescent Patients marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
As previously reported, in February 2023, Formycon and Fresenius Kabi entered into a global license agreement to commercialize FYB202, a ustekinumab biosimilar of Janssen’s.
No patent rights, no knowledge economy svensktnaringsliv.se - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from svensktnaringsliv.se Daily Mail and Mail on Sunday newspapers.
A path towards a crisis-proof EU pharmaceutical legislation? The European Commission proposal managingip.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from managingip.com Daily Mail and Mail on Sunday newspapers.